Bicocca Open Archive

Logo unimib boa
SQUILLACE, NICOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.405
AS - Asia 2.389
EU - Europa 2.364
SA - Sud America 536
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 9.759
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.297
SG - Singapore 799
CN - Cina 536
IT - Italia 504
RU - Federazione Russa 438
BR - Brasile 422
HK - Hong Kong 422
DE - Germania 403
SE - Svezia 306
VN - Vietnam 294
IE - Irlanda 253
GB - Regno Unito 118
ID - Indonesia 115
CA - Canada 76
UA - Ucraina 70
IN - India 60
FI - Finlandia 48
AR - Argentina 44
DK - Danimarca 42
NL - Olanda 34
PL - Polonia 31
AT - Austria 29
KR - Corea 29
ZA - Sudafrica 27
JP - Giappone 24
BD - Bangladesh 23
FR - Francia 23
MX - Messico 22
EC - Ecuador 19
BE - Belgio 15
CO - Colombia 14
TR - Turchia 13
IQ - Iraq 12
CH - Svizzera 10
PY - Paraguay 10
CL - Cile 9
ES - Italia 9
PE - Perù 8
PK - Pakistan 8
KE - Kenya 7
LT - Lituania 7
AE - Emirati Arabi Uniti 6
MY - Malesia 6
VE - Venezuela 6
AZ - Azerbaigian 5
CR - Costa Rica 5
EG - Egitto 5
CZ - Repubblica Ceca 4
IR - Iran 4
PH - Filippine 4
SA - Arabia Saudita 4
SN - Senegal 4
TN - Tunisia 4
UZ - Uzbekistan 4
BG - Bulgaria 3
BY - Bielorussia 3
EU - Europa 3
IL - Israele 3
KZ - Kazakistan 3
MA - Marocco 3
MD - Moldavia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
TH - Thailandia 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
KH - Cambogia 2
LU - Lussemburgo 2
MM - Myanmar 2
NG - Nigeria 2
NO - Norvegia 2
PR - Porto Rico 2
AL - Albania 1
BH - Bahrain 1
BO - Bolivia 1
BS - Bahamas 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
MN - Mongolia 1
PA - Panama 1
PT - Portogallo 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
Totale 9.759
Salva come PNG Salva come JPEG
Città #
Ann Arbor 926
Singapore 513
Hong Kong 422
Ashburn 381
Frankfurt am Main 288
Fairfield 281
New York 256
Dublin 244
Chandler 240
Wilmington 198
Houston 142
Woodbridge 142
Santa Clara 106
Seattle 105
Jakarta 104
Milan 104
Los Angeles 98
Princeton 91
Beijing 88
Ho Chi Minh City 85
Cambridge 75
Dallas 73
Hefei 68
Dearborn 56
Hanoi 52
Jacksonville 52
The Dalles 52
Dong Ket 41
Lawrence 41
Shanghai 41
São Paulo 41
Chicago 39
Altamura 38
Moscow 37
London 32
Guangzhou 30
Buffalo 29
Seoul 29
Nanjing 28
Rome 28
San Diego 26
Nuremberg 25
Ottawa 24
Tokyo 23
Rio de Janeiro 22
Helsinki 21
Johannesburg 20
Warsaw 20
Fremont 18
Brooklyn 16
Vienna 16
Amsterdam 14
Andover 14
Boston 14
Brussels 14
Council Bluffs 14
Munich 14
Falls Church 13
Boardman 12
Da Nang 12
Montreal 12
Denver 11
Lappeenranta 11
Monza 11
Phoenix 11
Toronto 11
Changsha 10
Curitiba 10
Pune 10
Salt Lake City 10
Stockholm 10
Lachine 9
Nanchang 9
Palermo 9
Atlanta 8
Biên Hòa 8
Chennai 8
Edmonton 8
Elk Grove Village 8
Guayaquil 8
Hangzhou 8
Poplar 8
Shenyang 8
Turin 8
Belo Horizonte 7
Bogotá 7
Brasília 7
Carate Brianza 7
Columbus 7
Jinan 7
Naples 7
Santo André 7
Zurich 7
Casorate Primo 6
Dhaka 6
Florence 6
Guarulhos 6
Lima 6
Mexico City 6
Mumbai 6
Totale 6.377
Salva come PNG Salva come JPEG
Nome #
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 303
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 276
Brief Report: Peripheral Monocyte/Macrophage Phenotypes Associated with the Evolution of Cognitive Performance in HIV-Infected Patients 275
Two-year cardio-pulmonary follow-up after severe COVID-19: a prospective study 268
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 265
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 260
Triglyceride/HDL ratio and its impact on the risk of diabetes mellitus development during ART 256
Brachial and central blood pressure in HIV-infected subjects 254
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 251
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 242
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 232
Switch da Tenofovir disoproxil fumarato (TDF) a Tenofovir alafenamide (TAF) e aumento del colesterolo: impatto sulla valutazione del rischio cardiovascolare 230
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 223
Positioning of darunavir/cobicistat-containing antiretroviral regimens in real life: Results from a large multicentre observational prospective cohort (SCOLTA) 216
Weight gain: A possible side effect of all antiretrovirals 213
Therapy of Sars-Coronavirus-2 pneumonia: is there an optimal IL-6 cut-off for successful tocilizumab treatment? 213
Unmasking tuberculosis in the era of antiretroviral treatment 212
A multidisciplinary approach to screen the post-COVID-19 conditions 210
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 209
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 201
Switching from efavirenz to rilpivirine improves sleep quality and self-perceived cognition but has no impact on neurocognitive performances 196
Invecchiare con la terapia antiretrovirale o essere anziani in terapia antiretrovirale: due profili di comorbidità differenti? 191
Arterial structure and function in AIDS patients: the impact of renal damage. 178
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 170
High-density lipoprotein-cholesterol levels and risk of cancer in HIV-infected subjects Data from the ICONA Foundation Cohort 168
The role for tocilizumab in covid-19 patients: Reflections on monza cohort data 162
Frailty and long-COVID: is COVID-19 responsible for a transition in frailty status among older adults who survived hospitalization for COVID-19? 156
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 155
Is It Feasible to Impact on Smoking Habits in HIV-Infected Patients? Mission Impossible from the STOPSHIV Project Cohort 153
Fattori associati con il ricovero ospedaliero per COVID-19 in 80 pazienti HIV-positivi italiani. Factors associated with hospital admission for COVID-19 in 80 Italian HIV patients. 151
Smoking Habits in Human Immunodeficiency Virus-Infected People from Italy: A Cross-Sectional Analysis of the STOPSHIV Cohort 151
Early changes in adhesion molecules expression and endothelial function in patients initiating ART with Atazanavir or Lopinavir 143
Causes of HIV Treatment Interruption during the Last 20 Years: A Multi-Cohort Real-Life Study 141
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 141
HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial 140
Factors Associated With Weight Gain in People Treated With Dolutegravir 139
Clusterization of co-morbidities and multi-morbidities among persons living with HIV: A cross-sectional study 138
Smoking habits in HIV-infected people compared with the general population in Italy: a cross-sectional study 137
Factors associated with hospital admission for COVID-19 in HIV patients 137
Metabolic syndrome and body weight in people living with HIV infection: analysis of differences observed in three different cohort studies over a decade 136
SLAM Project - Second-Level Diagnostic Assessment: Multidisciplinary approach to HIV Patients 135
Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort 134
Safety and tolerability of Elvitegravir/ Cobicistat/Emtricitabine/Tenofovir Disoproxil fumarate in a real life setting: Data from surveillance cohort long-term toxicity antiretrovirals/antivirals (SCOLTA) project 132
Arterial structural and functional effects of two different antiretroviral therapy protocol on naïve HIV-infected subjects 131
Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing? 127
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 127
Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens 124
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 124
Incident diabetes in course of antiretroviral therapy 122
Hepatitis C virus antibody-positive patients with HIV infection have a high risk of insulin resistance: A cross-sectional study 122
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9) 117
Lipid profile improvement in virologically suppressed HIV-1-infected patients switched to dolutegravir/abacavir/lamivudine: data from the SCOLTA project 116
Trajectories of CD4+/CD8+ T-Cells Ratio 96 Weeks after Switching to Dolutegravir-Based Two-Drug Regimens: Results from a Multicenter Prospective Cohort Study 111
Growing old with antiretroviral therapy or elderly people in antiretroviral therapy: two different profiles of comorbidity? 109
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir 106
The Effect of Switching from Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) on Liver Enzymes, Glucose, and Lipid Profile 103
Evidence gaps on weight gain in people living with HIV: a scoping review to define a research agenda 102
HIV and SARS-CoV-2 Co-Infection: What are the Risks? 93
Reversibility of Central Nervous System Adverse Events in Course of Art 93
Totale 10.120
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.536
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.536
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021844 0 0 0 0 0 175 126 139 94 117 61 132
2021/2022692 75 63 82 61 19 48 18 34 18 60 68 146
2022/20231.272 135 346 108 104 67 193 23 103 84 21 50 38
2023/20241.037 51 18 69 29 119 315 165 48 83 27 7 106
2024/20252.021 92 219 107 116 175 135 109 57 193 341 174 303
2025/20262.601 576 451 373 581 571 49 0 0 0 0 0 0
Totale 10.120